CSF biomarkers
neuronal injury
DYSFUNCTION
Biomarkers in the CSF of both treatments did not indicate any possible neuronal injury or dysfunction at baseline. In comparisons to normal sociodemographic ranges, the expressions were as follows: (1) normal: sAPPα, dopamine and BDNF; (2) elevated: sAPPβ and (3) low: NfL Aβ38, Aβ40, Aβ42.The concentrations of sAPPα (